Current NHS consultant posts held
Consultant Physician - Royal Free NHS Foundation Trust
Honorary Consultant - Royal Brompton NHS Foundation Trust
Consultant Physician - CLCH Community COPD services
Research interests
Interstitial Lung Disease
Asthma
COPD
NHS Improvement
Personal interests
Family
Travel
Cooking
Awards received
BMJ Innovations Award for Cancer (2016) - Ambulatory Lung Cancer.
Clinical Excellence Award – Level 9 (2018).
NHS Innovations Award Winner (2015) -
HSJ Award Finalist (2012) for Patient Safety and Integrated Care – Community COPD services in Barnet.
Raynaud’s and Scleroderma Trust Grant for 3 years (1990).
Distinctions at MBBS level.
State First -GCSE
(Additional) Languages spoken
- Tamil
- Fluent
- Hindi
- Conversational
Publications
R Abdullah · et al: Lung cancer tissue diagnosis in poor lung function: 2016; Thorax
Vancheeswaran R: Unexpected variations from the Junior Doctor Strike, May 2016; HSJ
G Greenhall, et al. Macrolide Therapy and Alveolar Hemorrhage Secondary to Granulomatosis with Polyangiitis 2015; Journal of Vasculitis
A N Tavare · et al: Ambulatory percutaneous lung biopsy with early discharge and Heimlich valve management of iatrogenic pneumothorax: More for less. 2015; Thorax.
Bloom, CI; et al (2013). Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLOS ONE 8; e70630.
Vancheeswaran R, et al. Pulmonary alveolar proteinosis –investigation and management. A review. Clinical Pulmonary Medicine. 2006,
Hunzelmann N, et al. Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma? Br J Dermatol. 1998 Dec; 139(6):1020-5.
Abraham, DJ et al. Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Am J Pathology. 1997, 151(3): 831-841.
Vancheeswaran R et al. Childhood onset scleroderma. Is it different from adult onset disease? Arthritis and Rheumatism. 1996; 39 (6): 1041- 1049.
Xu SW et al. Normal human and SSc fibroblasts retain typical phenotypic and functional characteristics following SV40-transfection. Experimental Cell Research. 1995; 220: 407
Bruckdorfer KR et al. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum. 1995 Aug; 38(8)
Gendi NS et al. HLA type as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic followup of 46 patients. Arthritis Rheum. 1995 Feb; 38(2)
Shi-Wen X et al. Expression and shedding of ICAM-1 and LFA-3 by SSc and normal fibroblasts. Arthritis and Rheumatism. 1994; 37
Vancheeswaran R et al. Circulating endothelin-1 levels suggest different pathogenic mechanisms in systemic sclerosis (SSc) subsets. Journal of Rheumatology 1994; 21
Vancheeswaran R et al. Localisation of endothelin-1 and its binding sites in scleroderma skin. Journal of Rheumatology 1994; 21.
Higley H et al. Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Arthritis Rheum. 1994 Feb; 37(2).
Courses offered to GPs
Expert on Demand Virtual Lectures
GP lectures for the Respiratory Masterclasses at Spire and other venues
Pharma sponsored evening lectures
GP Conference Plus Speaker